Pembrolizumab
Merck
['nsclc', 'lung', 'sclc', 'lcsm,(-blcsm)', 'pearls', 'pearl', 'pembro']
#esmo22 lung mini oral session outcomes of pearls (adjuvant pembro in resected nsclc) by pdl1 status shows dfs outcomes better in pdl1 &gt;50% as well as placebo #lcsm 
Thoracic Oncologist focused on immunotherapy for lung cancer & immune toxicity at Beaumont RCSI Cancer Centre Dublin; Adjunct Professor Johns Hopkins University